✦ LIBER ✦

High-dose cyclophosphamide and high-dose 5-fluorouracil: A new first-line regimen for advanced breast cancer

✍ Scribed by Lucien Israel; Jean-Luc Breau; Jacques Aguilera

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 443 KB
Volume: 53
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19840415)53:8<1655::aid-cncr2820530806>3.0.co;2-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An effective low-dose intermittent cyclo

An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer

✍ Richard H. Creech; Robert B. Catalano; Michael J. Mastrangelo; Paul F. Engstrom 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

A low-dose, three-drug regimen, C.M.F. (cyclophosphamide 50 mg, P.o., days 1-14; methotrexate, 25 mg, and 5-fluorouracil, 500 mg, i.v., days 1 and 8; cycled every 28 days) was used in 46 consecutive chemotherapy-eligible women (41 previously hormonally treated) with recurrent breast cancer. Thirteen

Cisplatin, 5-fluorouracil, and high-dose

Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer

✍ Everett E. Vokes; Richard L. Schilsky; Ralph R. Weichselbaum; Alfred Guaspari; C 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 626 KB

Mitoxantrone, 5-fluorouracil, and high d

Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma : A randomized Phase II trial

✍ John D. Hainsworth; Jacques Jolivet; Robert Birch; Lisa G. Hopkins; F. Anthony G 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Tenfour patients were treated with NFL: mitoxantrone 12 mg/m 2 IV on Day 1; leuconessee. vorin 300 mg IV over 30-60 minutes on Days 1, 2, and 3, immediately preceding

High dose folinic acid and 5-fluorouraci

High dose folinic acid and 5-fluorouracil bolus and continuous infusion for patients with advanced colorectal cancer

✍ Yves H. Bécouarn; René C. Brunet; Marie-Laurence P. Rouhier; Emmanuel J. Bussièr 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

High-dose medroxyprogesterone acetate in

High-dose medroxyprogesterone acetate in advanced breast cancer. Clinical and pharmacokinetic study with a combined oral and intramuscular regimen

✍ Reinhard Becher; Antonius A. Miller; Klaus Höffken; Udo Gerhold; Herbert Hirche; 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

High-dose cyclophosphamide and 5-fluorou

High-dose cyclophosphamide and 5-fluorouracil versus vincristine, doxorubicin, and cyclophosphamide in advanced carcinoma of the breast: A phase III study of the piedmont oncology association (POA)

✍ Patricia J. Zekan; Hyman B. Muss; Robert L. Capizzi; M. Robert Cooper; Robert W. 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

Forty-nine patients with advanced carcinoma of the breast who had received no prior chemotherapy were randomized to receive either high-dose cyclophosphamide (C) 1250 mg/M2 intravenously on day 1 and 5-fluorouracil (F) 600 mg/M2 intravenously on days 1 through 5 (CF), or vincristine (V) 1.5 mg/M2, d